Home
>
National Drug Code (NDC)
>
Mavik
Mavik - 54868-5099-1 - (Trandolapril)
Drug Information of Mavik
| Product NDC: | 54868-5099 |
| Proprietary Name: | Mavik |
| Non Proprietary Name: | Trandolapril |
| Active Ingredient(s): | 4 mg/1 & nbsp; Trandolapril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mavik
| Product NDC: | 54868-5099 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020528 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040625 |
Package Information of Mavik
| Package NDC: | 54868-5099-1 |
| Package Description: | 10 TABLET in 1 BOTTLE, PLASTIC (54868-5099-1) |
NDC Information of Mavik
| NDC Code | 54868-5099-1 |
| Proprietary Name | Mavik |
| Package Description | 10 TABLET in 1 BOTTLE, PLASTIC (54868-5099-1) |
| Product NDC | 54868-5099 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Trandolapril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040625 |
| Marketing Category Name | NDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | TRANDOLAPRIL |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
